Startup · United Kingdom
Frontier Space Technologies
HQ Nottingham, United KingdomFounded 20211-10 employeesUpdated
At Frontier Space, we enable next-generation biotechnology R&D in orbit—providing microgravity platforms for protein crystallisation, cell culture, antibody development, and preclinical drug testing to advance life on Earth and beyond.
Funding3 rounds
- Equity raised
- Undisclosed
- Debt, secondaries & grants
- ~$810K
- Latest
- ~$494KGrant · Mar 19, 2026
| Announced | Stage | Amount | Valuation | Lead investors | Other investors | Confidence |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Grant | ~$494K | — | UK Space Agency | — | Reported |
| May 15, 2024 | Pre-Seed | Undisclosed | — | Seraphim Space | — | Reported |
| May 8, 2024 | Grant | ~$316K | — | — | — | Reported |
- GrantLed by UK Space Agency~$494KMar 19, 2026
- Pre-SeedLed by Seraphim SpaceUndisclosedMay 15, 2024
- Grant~$316KMay 8, 2024
Raised counts equity rounds; debt, secondary sales and grants are totaled separately. Amounts in other currencies are converted at the announcement month's average rate. A ~ marks an estimated or converted amount.
Systems1
- SpaceLabA modular laboratory payload for in-orbit biological research and manufacturing.
Newest unveiled first. Systems that belong to a government program link to the program page, where variants, costs and contracts are.
Capabilities2
| Technology | Role | Maturity | TRL | Notes | Confidence |
|---|---|---|---|---|---|
| Biotechnology and biomanufacturing | Developer | — | — | classify_sectors run 37, haiku, taxonomy 2026-10-18b: Provides in-orbit microgravity platforms for biotech R&D, with no defense use stated. | Reported |
| Space, launch and counterspace | Developer | — | — | classify_sectors run 37, haiku, taxonomy 2026-10-18b: Provides in-orbit microgravity platforms for biotech R&D, with no defense use stated. | Reported |
- Developerclassify_sectors run 37, haiku, taxonomy 2026-10-18b: Provides in-orbit microgravity platforms for biotech R&D, with no defense use stated.—Reported
- Developerclassify_sectors run 37, haiku, taxonomy 2026-10-18b: Provides in-orbit microgravity platforms for biotech R&D, with no defense use stated.—Reported
Maturity and TRL describe this organization's work; the field-wide maturity is on each technology's page.
People1
| Person | Role |
|---|---|
| Aqeel Shamsul | Chief Executive Officer |
Sources7
Profile3
- 1
Sixth-Domain · Supports Organization · country, Organization · kind
“{"country": "UK", "hq_iso2": "GB", "id": "32b937b9-9def-413a-bfdd-4e1f8e8c2915"}”
- 2
Crunchbase · Supports Organization · employee range, Organization · hq city, Organization · linkedin url, Organization · x url
“employee_range: 1-10 (profile: 1-10)”
- 3CompanyHome | Frontier Space
Frontier Space Technologies · Supports Organization · description, Organization · name, Organization · website
“At Frontier Space, we enable next-generation biotechnology R&D in orbit—providing microgravity platforms for protein crystallisation, cell culture, antibody development, and preclinical drug testing to advance life on Earth and beyond.”
Systems1
- 4CompanyR&D | Frontier Space
Frontier Space Technologies · Supports System
“Our primary product offering is SpaceLab; a scalable, modular, autonomous lab-in-a-box capable of industrialising in-orbit manufacturing of high-value bioproducts and hosting biopharma R&D.”
Funding3
- 5
LinkedIn (Frontier Space) · Mar 19, 2026 · Supports Funding round · amount
“Frontier Space has been awarded funding from the UK Space Agency’s International Bilateral Fund (IBF) to lead Project BRIDGE”
- 6
Caplight · Supports Funding round · amount
“$494K grant from the UK Space Agency”
- 7
LinkedIn · Supports Funding round, Organization · employee range, Organization · founded year, Organization · hq city, Organization · linkedin url, Organization · ownership, Role
“funding round: Grant, 2024-05-08, GBP 250,000, lead: UK Space Agency”
Each fact on this page is attached to the sources that support it. Archived copies are linked when we keep one.